CS logo
small CS logo
Volga District Med Center FMBA

Nizhny Novgorod, Russian Federation
General hospital in Nizhny Novgorod
Ulitsa Goncharova, 1Д, Nizhny Novgorod, Nizhny Novgorod Oblast, 603032

About Volga District Med Center FMBA


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Eisai Inc.
1
Ferring Pharmaceuticals
1
Total Rows: 3

Clinical Trials at Volga District Med Center FMBA


During the past decade, Volga District Med Center FMBA conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220011000011000000000022Started TrialsCompleted Trails2016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
2016-04-19
2021-03-29
Terminated
545
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
2016-10-13
2024-10-31
Active, not recruiting
1,069
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
2018-05-31
2020-10-27
Completed
175
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
2021-02-23
2025-09-26
Active, not recruiting
662

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Volga District Med Center FMBA" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBayer: 2Bayer: 2Eisai Inc.: 1Eisai Inc.: 1Ferring Pharmaceuticals: 1Ferring Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsDuke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1Memorial SloanKettering CancerCenter: 1Memorial SloanKettering CancerCenter: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Orion Corporation,Orion Pharma: 1Orion Corporation,Orion Pharma: 1

Clinical Trials Conditions at Volga District Med Center FMBA


According to Clinical.Site data, the most researched conditions in "Volga District Med Center FMBA" are "Carcinoma, Transitional Cell" (1 trials), "Prostate Cancer" (1 trials), "Prostatic Neoplasms" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Volga District Med Center FMBA" in a lesser frequency.

Clinical Trials Intervention Types at Volga District Med Center FMBA


Most popular intervention types in "Volga District Med Center FMBA" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Androgen deprivation therapy (ADT)" (1 trials), "Chemotherapy" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Degarelix" (1 trials) and "Everolimus" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Volga District Med Center FMBA


The vast majority of trials in "Volga District Med Center FMBA" are 2 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Volga District Med Center FMBA


Currently, there are NaN active trials in "Volga District Med Center FMBA". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Volga District Med Center FMBA, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Volga District Med Center FMBA, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 2Active, not recruiting: 2Completed: 1Completed: 1Terminated: 1Terminated: 1

Departments of Volga District Med Center FMBA


Volga District Med Center FMBA has several departments that took part in Clinical trials: "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" - 2 trials
Departments List
Total Rows: 1